Pfizer CEO calls on industry to increase R&D efficiency

07/28/2008 | Bloomberg

Drugmakers need to boost "efficiencies in research and development" to bolster innovation, Pfizer CEO Jeff Kindler told Bloomberg Television. Kindler's decision to divide Pfizer's R&D operation into smaller therapeutic units helped replenish its pipeline, which may have as many as 28 treatments in late-stage development by the end of 2009.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ